Harte Hanks Inc (NYSE:HHS) was the target of a large growth in short interest in June. As of June 30th, there was short interest totalling 32,800 shares, a growth of 15.5% from the May 30th total of 28,400 shares. Based on an average daily volume of 5,200 shares, the short-interest ratio is presently 6.3 days. Approximately 0.9% of the company’s stock are short sold.
Separately, ValuEngine downgraded shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st.
Shares of Harte Hanks stock traded down $0.03 on Friday, reaching $2.81. 5,195 shares of the company traded hands, compared to its average volume of 3,629. Harte Hanks has a 52 week low of $2.20 and a 52 week high of $11.35. The business has a 50 day moving average of $2.78. The stock has a market cap of $17.62 million, a price-to-earnings ratio of -3.05 and a beta of 1.07.
Harte Hanks (NYSE:HHS) last released its earnings results on Wednesday, May 8th. The business services provider reported ($1.48) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.77) by ($0.71). The firm had revenue of $59.15 million for the quarter, compared to analysts’ expectations of $57.50 million.
About Harte Hanks
Harte Hanks, Inc provides various multi-channel marketing services in the United States and internationally. The company provides agency services, such as customer engagement solutions in direct and digital communications for consumer and business-to-business markets; digital services, including search engine management, display, digital analytics, Website development and design, digital strategy, social media, email, e-commerce, and interactive relationship management services; and database marketing and business-to-business lead generation solutions that offer insight and analytics, customer data integration, and marketing communications tools.
Featured Story: Debt-To-Equity Ratio
Receive News & Ratings for Harte Hanks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harte Hanks and related companies with MarketBeat.com's FREE daily email newsletter.